Alzheimer’s Research and Treatment Center at Neurological Associates of Albany is committed to the highest level of care for all of our patients. Patients that are enrolled in our studies have access to the latest in Alzheimer’s therapies in a setting where patients can feel comfortable and connected. Your satisfaction is our primary concern. We work closely with patients and caregivers in order to provide unique treatments that are on the cutting edge of cognitive innovation, all of which are compliant with FDA guidelines.
The staff at Alzheimer’s Research and Treatment Center at Neurological Associates of Albany have all dedicated themselves to working with Alzheimer’s and other neurological patients. This dedication and passion along with the combined knowledge of all of our doctors results in unrivaled care for all of the NAA’s patients.
The Benefits of our Patients
- Patients have access to the most innovative treatments
- Examination and treatment by experts in the field of Alzheimer’s and other dementias
- Initial assessment, memory testing, and examination
- Access to the latest medications
- Treatment with latest studies under FDA guidelines
Dr. Richard Holub is president of Alzheimer’s Research and Treatment Center at Neurological Associates of Albany, PC (NAA) an organization that consists of a highly respected clinic providing a full complement of neurological services and a well established research center. The clinical arm of NAA currently has a panel of over 2,000 patients and provides comprehensive neurological services to over 1,000 patients diagnosed with Alzheimer’s disease, MCI, or other forms of dementia.
In addition of providing high quality neurological care, Dr. Holub is also the principal investigator for the Research Division of NAA, where he has been conducting phase II and Phase III clinical trials for over 30 years. During his impressive career, Dr. Holub has conducted over 100 successful clinical trials and has played a significant role in the investigation of all five drugs currently approved by the FDA for the Treatment of Alzheimer’s Disease, he has also been involved in clinical trials investigation treatments for Major Depression, Generalized Anxiety Disorder, Multiple Sclerosis, and painful Diabetic Neuropathy among others.
NAA’s Research Division encompasses over 3,000 square feet of space and houses three experienced research coordinators, two psychomatricians, a physician’s assistant as well as lab and support personnel. The office has a fully functioning lab, a two-chair infusion suite, three exam rooms and two testing rooms. NAA also has long standing professional relationships with a number of local imaging centers which allows it to conduct all of the activities that are a typical part of any standard clinical trial.
Since NAA staff prescreens every patient, the division’s screen failure rate is very low. NAA is noted for our ability to recruit high numbers of eligible patients and associated high retention rates.
Our clinic is one of the leading centers in New York State conducting clinical trials. Talk with us! Get involved today.
Why Clinical Trials for Alzheimer’s Are Necessary
What a great world it would be if we knew how to prevent, or even cure, all types of cognitive impairment disorders.
Medical providers do all they can with conventional therapies, but to treat Alzheimer’s long term, we must also incorporate innovative therapies beyond the standard of care.
Since nearly all of today’s Alzheimer’s treatments began with breakthrough discoveries emanating from clinical trials, providing Alzheimer’s patients with access to these trials can significantly improve their prospects and is, therefore, a crucial component of a comprehensive Alzheimer’s care program.
Whether patients receive a placebo or the therapy being tested, they are likely to perform better than patients receiving conventional care because of the extra attention they get.
As part of the trial protocol, clinical trial patients are seen more frequently, receive regular extensive evaluations, and in the case of patients involved in clinical trials are repeatedly evaluated for several years to measure the effectiveness of the tested therapy.
There’s a psychological benefit, too; just knowing they are part of a clinical trial improves the mental outlook of patients struggling with serious illness.
The community also gains something when a local institution/clinic engages in clinical trials. The best and the brightest minds in medicine are drawn to institutions/clinics where they can conduct clinical research; their skill and knowledge benefit all patients, not just those participating in clinical trials.
Contact Us to get involved in clinical research today!
If you or a loved one has been diagnosed with Alzheimer’s or have experienced noticeable memory loss, you should know about our study evaluating a drug aimed at halting the progression of mild Alzheimer’s.
Participants in this study will receive study-related care from a team of medical professionals, study-related exams, and the study drug after the clinical trial is complete, all at no cost.
If you are interested to see if you pre-qualify for this study, please take our pre-screener. You will be asked a series of questions about either your Alzheimer’s or answering on behalf of the person with Alzheimer’s for whom you are caring. The information you provide will not be shared without your consent.